Task: Answer the multiple-choice question.
Question: Which drug exhibits a -22.930% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: O=C(NCC1CCCO1)/C(=C\c1ccco1)NC(=O)c1ccccc1
b: COc1ccc2c(-c3ccccc3)cc(SCC(=O)N(C)C)nc2c1
Answer: b. COc1ccc2c(-c3ccccc3)cc(SCC(=O)N(C)C)nc2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc2c(-c3ccccc3)cc(SCC(=O)N(C)C)nc2c1
COc1ccc2c(-c3ccccc3)cc(SCC(=O)N(C)C)nc2c1
2-(7-methoxy-4-phenylquinolin-2-yl)sulfanyl-N,N-dimethylacetamide